Bispecific Antibody Market Report

China Bispecific Antibody Industry Market Research Report 2023-2029

  • POSTDATE：Aug 25, 2023
  • PAGES：155
  • REPORT CODE：GMM1755765
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Bispecific Antibody industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Ablynx

    • Sanofi

    • Immunomedics

    • Chugai Pharmaceutical

    • MacroGenics

    • AstraZeneca (MedImmune)

    • Emergent BioSolutions

    • Pieris

    • EMD Serono

    • Eli Lilly

    • Amgen

    • Merus

    • Regeneron Pharmaceuticals

    • Affimed Therapeutics

    • Adimab

    • Genentech

    • Jounce Therapeutics

    • Neovii Biotech

    • Genmab

    By Type:

    • Mab or Peptide

    • Small Molecule

    • CAR-T

    • ADC

    • Bispecific mAb

    • BiTE

    By Application:

    • Cardiovascular

    • Solid Tumors

    • Oncology

    • Inflammation

    • General Medicine

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Bispecific Antibody Market Overview 2018-2029

    • 1.1 China Bispecific Antibody Industry Development Overview

    • 1.2 China Bispecific Antibody Industry Development History

    • 1.3 China Bispecific Antibody Industry Market Size (2018-2029)

    • 1.4 China Bispecific Antibody Market Analysis by Type from Production Side

      • 1.4.1 China Bispecific Antibody Production Volume, Production Value and Growth Rate of Mab or Peptide (2018-2029)

      • 1.4.2 China Bispecific Antibody Production Volume, Production Value and Growth Rate of Small Molecule (2018-2029)

      • 1.4.3 China Bispecific Antibody Production Volume, Production Value and Growth Rate of CAR-T (2018-2029)

      • 1.4.4 China Bispecific Antibody Production Volume, Production Value and Growth Rate of ADC (2018-2029)

      • 1.4.5 China Bispecific Antibody Production Volume, Production Value and Growth Rate of Bispecific mAb (2018-2029)

      • 1.4.6 China Bispecific Antibody Production Volume, Production Value and Growth Rate of BiTE (2018-2029)

    • 1.5 China Bispecific Antibody Market Analysis by Application from Consumption End

      • 1.5.1 China Bispecific Antibody Sales Volume, Sales Value and Growth Rate of Cardiovascular (2018-2029)

      • 1.5.2 China Bispecific Antibody Sales Volume, Sales Value and Growth Rate of Solid Tumors (2018-2029)

      • 1.5.3 China Bispecific Antibody Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

      • 1.5.4 China Bispecific Antibody Sales Volume, Sales Value and Growth Rate of Inflammation (2018-2029)

      • 1.5.5 China Bispecific Antibody Sales Volume, Sales Value and Growth Rate of General Medicine (2018-2029)

    • 1.6 China Bispecific Antibody Market Analysis by Region

      • 1.6.1 North China Bispecific Antibody Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Bispecific Antibody Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Bispecific Antibody Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Bispecific Antibody Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Bispecific Antibody Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Bispecific Antibody Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Bispecific Antibody Market Size and Growth Rate from 2018-2029

    Chapter 2 China Bispecific Antibody Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Bispecific Antibody Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Bispecific Antibody Market Status and Competition Analysis in 2023

      • 2.2.3 China Bispecific Antibody Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Bispecific Antibody Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Bispecific Antibody Industry Development

    Chapter 3 Bispecific AntibodyIndustry Chain Analysis

    • 3.1 Bispecific Antibody Industry Chain

    • 3.2 Bispecific Antibody Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Bispecific Antibody Market

    • 3.3 Bispecific Antibody Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Bispecific Antibody Market

    Chapter 4 China Bispecific Antibody Market, by Type

    • 4.1 China Bispecific Antibody Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Bispecific Antibody Total Production Volume and Growth Rate from Production Side

    • 4.5 China Bispecific Antibody Production Volume and Growth Rate, by Type

      • 4.5.1 China Bispecific Antibody Production Volume and Growth Rate of Mab or Peptide

      • 4.5.2 China Bispecific Antibody Production Volume and Growth Rate of Small Molecule

      • 4.5.3 China Bispecific Antibody Production Volume and Growth Rate of CAR-T

      • 4.5.4 China Bispecific Antibody Production Volume and Growth Rate of ADC

      • 4.5.5 China Bispecific Antibody Production Volume and Growth Rate of Bispecific mAb

      • 4.5.6 China Bispecific Antibody Production Volume and Growth Rate of BiTE

    Chapter 5 China Bispecific Antibody Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Bispecific Antibody Total Market Size and Growth Rate from Consumption End

    • 5.5 China Bispecific Antibody Market Size and Growth Rate, by Application

      • 5.5.1 China Bispecific Antibody Market Size and Growth Rate of Cardiovascular

      • 5.5.2 China Bispecific Antibody Market Size and Growth Rate of Solid Tumors

      • 5.5.3 China Bispecific Antibody Market Size and Growth Rate of Oncology

      • 5.5.4 China Bispecific Antibody Market Size and Growth Rate of Inflammation

      • 5.5.5 China Bispecific Antibody Market Size and Growth Rate of General Medicine

    Chapter 6 China Bispecific Antibody Market, by Region

    • 6.1 China Bispecific Antibody Production Volume and Production Value, by Region

    • 6.2 China Bispecific Antibody Sales Volume and Sales Value, by Region

    Chapter 7 North China Bispecific Antibody Market Analysis

    • 7.1 North China Bispecific Antibody Market, by Type

    • 7.2 North China Bispecific Antibody Market, by Application

    Chapter 8 Central China Bispecific Antibody Market Analysis

    • 8.1 Central China Bispecific Antibody Market, by Type

    • 8.2 Central China Bispecific Antibody Market, by Application

    Chapter 9 South China Bispecific Antibody Market Analysis

    • 9.1 South China Bispecific Antibody Market, by Type

    • 9.2 South China Bispecific Antibody Market, by Application

    Chapter 10 East China Bispecific Antibody Market Analysis

    • 10.1 East China Bispecific Antibody Market, by Type

    • 10.2 East China Bispecific Antibody Market, by Application

    Chapter 11 Northeast China Bispecific Antibody Market Analysis

    • 11.1 Northeast China Bispecific Antibody Market, by Type

    • 11.2 Northeast China Bispecific Antibody Market, by Application

    Chapter 12 Southwest China Bispecific Antibody Market Analysis

    • 12.1 Southwest China Bispecific Antibody Market, by Type

    • 12.2 Southwest China Bispecific Antibody Market, by Application

    Chapter 13 Northwest China Bispecific Antibody Market Analysis

    • 13.1 Northwest China Bispecific Antibody Market, by Type

    • 13.2 Northwest China Bispecific Antibody Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Ablynx

        • 14.1.1 Ablynx Company Profile

        • 14.1.2 Ablynx Bispecific Antibody Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Sanofi

        • 14.2.1 Sanofi Company Profile

        • 14.2.2 Sanofi Bispecific Antibody Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Immunomedics

        • 14.3.1 Immunomedics Company Profile

        • 14.3.2 Immunomedics Bispecific Antibody Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Chugai Pharmaceutical

        • 14.4.1 Chugai Pharmaceutical Company Profile

        • 14.4.2 Chugai Pharmaceutical Bispecific Antibody Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 MacroGenics

        • 14.5.1 MacroGenics Company Profile

        • 14.5.2 MacroGenics Bispecific Antibody Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 AstraZeneca (MedImmune)

        • 14.6.1 AstraZeneca (MedImmune) Company Profile

        • 14.6.2 AstraZeneca (MedImmune) Bispecific Antibody Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Emergent BioSolutions

        • 14.7.1 Emergent BioSolutions Company Profile

        • 14.7.2 Emergent BioSolutions Bispecific Antibody Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Pieris

        • 14.8.1 Pieris Company Profile

        • 14.8.2 Pieris Bispecific Antibody Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 EMD Serono

        • 14.9.1 EMD Serono Company Profile

        • 14.9.2 EMD Serono Bispecific Antibody Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Eli Lilly

        • 14.10.1 Eli Lilly Company Profile

        • 14.10.2 Eli Lilly Bispecific Antibody Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Amgen

        • 14.11.1 Amgen Company Profile

        • 14.11.2 Amgen Bispecific Antibody Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Merus

        • 14.12.1 Merus Company Profile

        • 14.12.2 Merus Bispecific Antibody Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Regeneron Pharmaceuticals

        • 14.13.1 Regeneron Pharmaceuticals Company Profile

        • 14.13.2 Regeneron Pharmaceuticals Bispecific Antibody Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Affimed Therapeutics

        • 14.14.1 Affimed Therapeutics Company Profile

        • 14.14.2 Affimed Therapeutics Bispecific Antibody Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Adimab

        • 14.15.1 Adimab Company Profile

        • 14.15.2 Adimab Bispecific Antibody Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Genentech

        • 14.16.1 Genentech Company Profile

        • 14.16.2 Genentech Bispecific Antibody Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Jounce Therapeutics

        • 14.17.1 Jounce Therapeutics Company Profile

        • 14.17.2 Jounce Therapeutics Bispecific Antibody Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Neovii Biotech

        • 14.18.1 Neovii Biotech Company Profile

        • 14.18.2 Neovii Biotech Bispecific Antibody Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Genmab

        • 14.19.1 Genmab Company Profile

        • 14.19.2 Genmab Bispecific Antibody Market Performance

        • 14.19.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Bispecific Antibody Industry Research Conclusions

    • 15.2 Bispecific Antibody Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Bispecific Antibody Industry Market Size (2018-2029)

    • Figure China Bispecific Antibody Production Volume, Production Value and Growth Rate of Mab or Peptide (2018-2029)

    • Figure China Bispecific Antibody Production Volume, Production Value and Growth Rate of Small Molecule (2018-2029)

    • Figure China Bispecific Antibody Production Volume, Production Value and Growth Rate of CAR-T (2018-2029)

    • Figure China Bispecific Antibody Production Volume, Production Value and Growth Rate of ADC (2018-2029)

    • Figure China Bispecific Antibody Production Volume, Production Value and Growth Rate of Bispecific mAb (2018-2029)

    • Figure China Bispecific Antibody Production Volume, Production Value and Growth Rate of BiTE (2018-2029)

    • Figure China Bispecific Antibody Sales Volume, Sales Value and Growth Rate of Cardiovascular (2018-2029)

    • Figure China Bispecific Antibody Sales Volume, Sales Value and Growth Rate of Solid Tumors (2018-2029)

    • Figure China Bispecific Antibody Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure China Bispecific Antibody Sales Volume, Sales Value and Growth Rate of Inflammation (2018-2029)

    • Figure China Bispecific Antibody Sales Volume, Sales Value and Growth Rate of General Medicine (2018-2029)

    • Figure North China Bispecific Antibody Market Size and Growth Rate from 2018-2029

    • Figure Central China Bispecific Antibody Market Size and Growth Rate from 2018-2029

    • Figure South China Bispecific Antibody Market Size and Growth Rate from 2018-2029

    • Figure East China Bispecific Antibody Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Bispecific Antibody Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Bispecific Antibody Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Bispecific Antibody Market Size and Growth Rate from 2018-2029

    • Figure Bispecific Antibody Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Bispecific Antibody Market Share by Type in 2018

    • Figure China Bispecific Antibody Market Share by Type in 2023

    • Figure China Bispecific Antibody Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Bispecific Antibody Production Volume and Growth Rate of Mab or Peptide (2018-2023)

    • Figure China Bispecific Antibody Production Volume and Growth Rate of Small Molecule (2018-2023)

    • Figure China Bispecific Antibody Production Volume and Growth Rate of CAR-T (2018-2023)

    • Figure China Bispecific Antibody Production Volume and Growth Rate of ADC (2018-2023)

    • Figure China Bispecific Antibody Production Volume and Growth Rate of Bispecific mAb (2018-2023)

    • Figure China Bispecific Antibody Production Volume and Growth Rate of BiTE (2018-2023)

    • Figure China Bispecific Antibody Market Share by Application in 2018

    • Figure China Bispecific Antibody Market Share by Application in 2023

    • Figure China Bispecific Antibody Total Market Size and Growth Rate from Consumption End

    • Figure China Bispecific Antibody Market Size and Growth Rate of Cardiovascular (2018-2023)

    • Figure China Bispecific Antibody Market Size and Growth Rate of Solid Tumors (2018-2023)

    • Figure China Bispecific Antibody Market Size and Growth Rate of Oncology (2018-2023)

    • Figure China Bispecific Antibody Market Size and Growth Rate of Inflammation (2018-2023)

    • Figure China Bispecific Antibody Market Size and Growth Rate of General Medicine (2018-2023)

    • Table China Bispecific Antibody Production Volume by Region (2018-2023)

    • Table China Bispecific Antibody Production Volume Share by Region (2018-2023)

    • Figure China Bispecific Antibody Production Volume Share by Region (2018-2023)

    • Table China Bispecific Antibody Production Value by Region (2018-2023)

    • Table China Bispecific Antibody Production Value Share by Region (2018-2023)

    • Figure China Bispecific Antibody Production Value Share by Region (2018-2023)

    • Table China Bispecific Antibody Sales Volume by Region (2018-2023)

    • Table China Bispecific Antibody Sales Volume Share by Region (2018-2023)

    • Figure China Bispecific Antibody Sales Volume Share by Region (2018-2023)

    • Table China Bispecific Antibody Sales Value by Region (2018-2023)

    • Table China Bispecific Antibody Sales Value Share by Region (2018-2023)

    • Figure China Bispecific Antibody Sales Value Share by Region (2018-2023)

    • Table North China Bispecific Antibody Production Volume by Type (2018-2023)

    • Table North China Bispecific Antibody Production Volume Share by Type (2018-2023)

    • Figure North China Bispecific Antibody Production Volume Share by Type (2018-2023)

    • Table North China Bispecific Antibody Sales Volume by Application (2018-2023)

    • Table North China Bispecific Antibody Sales Volume Share by Application (2018-2023)

    • Figure North China Bispecific Antibody Sales Volume Share by Application (2018-2023)

    • Table Central China Bispecific Antibody Production Volume by Type (2018-2023)

    • Table Central China Bispecific Antibody Production Volume Share by Type (2018-2023)

    • Figure Central China Bispecific Antibody Production Volume Share by Type (2018-2023)

    • Table Central China Bispecific Antibody Sales Volume by Application (2018-2023)

    • Table Central China Bispecific Antibody Sales Volume Share by Application (2018-2023)

    • Figure Central China Bispecific Antibody Sales Volume Share by Application (2018-2023)

    • Table South China Bispecific Antibody Production Volume by Type (2018-2023)

    • Table South China Bispecific Antibody Production Volume Share by Type (2018-2023)

    • Figure South China Bispecific Antibody Production Volume Share by Type (2018-2023)

    • Table South China Bispecific Antibody Sales Volume by Application (2018-2023)

    • Table South China Bispecific Antibody Sales Volume Share by Application (2018-2023)

    • Figure South China Bispecific Antibody Sales Volume Share by Application (2018-2023)

    • Table East China Bispecific Antibody Production Volume by Type (2018-2023)

    • Table East China Bispecific Antibody Production Volume Share by Type (2018-2023)

    • Figure East China Bispecific Antibody Production Volume Share by Type (2018-2023)

    • Table East China Bispecific Antibody Sales Volume by Application (2018-2023)

    • Table East China Bispecific Antibody Sales Volume Share by Application (2018-2023)

    • Figure East China Bispecific Antibody Sales Volume Share by Application (2018-2023)

    • Table Northeast China Bispecific Antibody Production Volume by Type (2018-2023)

    • Table Northeast China Bispecific Antibody Production Volume Share by Type (2018-2023)

    • Figure Northeast China Bispecific Antibody Production Volume Share by Type (2018-2023)

    • Table Northeast China Bispecific Antibody Sales Volume by Application (2018-2023)

    • Table Northeast China Bispecific Antibody Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Bispecific Antibody Sales Volume Share by Application (2018-2023)

    • Table Southwest China Bispecific Antibody Production Volume by Type (2018-2023)

    • Table Southwest China Bispecific Antibody Production Volume Share by Type (2018-2023)

    • Figure Southwest China Bispecific Antibody Production Volume Share by Type (2018-2023)

    • Table Southwest China Bispecific Antibody Sales Volume by Application (2018-2023)

    • Table Southwest China Bispecific Antibody Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Bispecific Antibody Sales Volume Share by Application (2018-2023)

    • Table Northwest China Bispecific Antibody Production Volume by Type (2018-2023)

    • Table Northwest China Bispecific Antibody Production Volume Share by Type (2018-2023)

    • Figure Northwest China Bispecific Antibody Production Volume Share by Type (2018-2023)

    • Table Northwest China Bispecific Antibody Sales Volume by Application (2018-2023)

    • Table Northwest China Bispecific Antibody Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Bispecific Antibody Sales Volume Share by Application (2018-2023)

    • Table Ablynx Company Profile

    • Table Ablynx Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table Immunomedics Company Profile

    • Table Immunomedics Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table Chugai Pharmaceutical Company Profile

    • Table Chugai Pharmaceutical Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table MacroGenics Company Profile

    • Table MacroGenics Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca (MedImmune) Company Profile

    • Table AstraZeneca (MedImmune) Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table Emergent BioSolutions Company Profile

    • Table Emergent BioSolutions Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table Pieris Company Profile

    • Table Pieris Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table EMD Serono Company Profile

    • Table EMD Serono Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table Merus Company Profile

    • Table Merus Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table Regeneron Pharmaceuticals Company Profile

    • Table Regeneron Pharmaceuticals Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table Affimed Therapeutics Company Profile

    • Table Affimed Therapeutics Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table Adimab Company Profile

    • Table Adimab Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table Genentech Company Profile

    • Table Genentech Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table Jounce Therapeutics Company Profile

    • Table Jounce Therapeutics Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table Neovii Biotech Company Profile

    • Table Neovii Biotech Bispecific Antibody Revenue, Price and Gross (2018-2023)

    • Table Genmab Company Profile

    • Table Genmab Bispecific Antibody Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US